Laddar...
Cellular factors promoting resistance to effective treatment of glioma with oncolytic Myxoma virus
Oncolytic virus therapy is being evaluated in clinical trials for human glioma. While it is widely assumed that the patient's immune response to the virus infection limits the therapy's utility, investigations into the specific cell type(s) involved in this response have been performed usi...
Sparad:
| I publikationen: | Cancer Res |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4281961/ https://ncbi.nlm.nih.gov/pubmed/25336188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-0876 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|